Introduction HIV-exposed uninfected children may be at risk of poor neurodevelopment. We aimed to test the impact of improved infant and young child feeding (IYCF) and improved water, sanitation and hygiene (WASH) on early child development (ECD) outcomes. Methods Sanitation Hygiene Infant Nutrition Efficacy was a cluster randomised 2×2 factorial trial in rural Zimbabwe ClinicalTrials.gov NCT01824940). Pregnant women were eligible if they lived in study clusters allocated to standard-of-care (SOC; 52 clusters); IYCF (20 g small-quantity lipid-based nutrient supplement/day from 6 to 18 months, complementary feeding counselling; 53 clusters); WASH (pit latrine, 2 hand-washing stations, liquid soap, chlorine, play space, hygiene counselling; 53 clusters) or IYCF +WASH (53 clusters). Participants and fieldworkers were not blinded. ECD was assessed at 24 months using the Malawi Developmental Assessment Tool (MDAT; assessing motor, cognitive, language and social skills); MacArthur Bates Communication Development Inventory (assessing vocabulary and grammar); A-not-B test (assessing object permanence) and a self-control task. Intention-to-treat analyses were stratified by maternal HIV status. Results Compared with SOC, children randomised to combined IYCF +WASH had higher total MDAT scores (mean difference +4.6; 95% CI 1.9 to 7.2) and MacArthur Bates vocabulary scores (+8.5 words; 95% CI 3.7 to 13.3), but there was no evidence of effects from IYCF or WASH alone. There was no evidence that that any intervention impacted object permanence or self-control. Conclusions Combining IYCF and WASH interventions significantly improved motor, language and cognitive development in HIV-exposed children. Trial registration number NCT01824940.
The SHINE trial design has been reported previously; the protocol and statistical analysis plan are available at https://osf.io/w93hy Briefly, SHINE was a cluster randomised, community-based 2×2 factorial trial conducted in two contiguous rural districts in Zimbabwe. Clusters were defined as the catchment area of 1–4 village health workers (VHWs) employed by the Ministry of Health and Child Care, and were allocated to one of four treatment groups (standard-of-care (SOC), IYCF, WASH, IYCF +WASH) at a public randomisation event. A highly constrained randomisation technique achieved balance across arms for 14 variables related to geography, demography, water access and sanitation coverage. Between 22 November 2012 and 27 March 2015, VHWs identified pregnant women and referred them to trial research nurses, who enrolled women permanently residing in the study area into SHINE following written informed consent. HIV prevalence among antenatal women in the study area was 15%; we prespecified that analysis of all outcomes would be stratified by maternal HIV status. Interventions were informed by extensive formative research and piloting.7 Behavioural change modules using interactive tools to deliver specific messages were provided by arm-specific VHWs; lesson plans and intervention tools are publicly accessible at https://osf.io/w93hy. All women were scheduled to receive 15 VHW visits between enrolment and 12 months postpartum; other family members were encouraged to participate. At each visit, previous information was reviewed before introducing new information to create a sequenced, integrated, longitudinal intervention. Between 13 and 17 months, VHWs visited monthly, providing routine care and, in active arms, delivering intervention supplies; during these visits VHWs informally encouraged participants to practise relevant behaviours. At 18 months, a review module was delivered in all arms. Key messages and supplies are outlined below, with more detail provided in the online supplementary methods: bmjgh-2019-001718supp001.pdf A latrine was constructed in non-WASH arms following trial completion. Masking for participants and fieldworkers was not possible, but investigators were blinded to trial arm. Local clinics undertook antenatal HIV testing and provided antiretroviral therapy (ART) to HIV-positive women. PMTCT guidelines in Zimbabwe changed from WHO Option B (combination ART for all HIV-positive women during the pregnancy and breast feeding) to Option B+ (lifelong ART for pregnant and breastfeeding women) during the trial (from November 2013). In addition to local clinic services, we offered home HIV testing to mothers at baseline using an anti-HIV antibody rapid test algorithm (Alere Determine HIV-1/2 test, confirmed by INSTI HIV-1/2 test if positive); testing was repeated at 32 gestational weeks to detect HIV seroconversion during pregnancy. Women testing HIV-positive had CD4 counts measured (Alere Pima, Abbott) and were referred to local clinics for ART. The trial did not measure HIV viral loads. HIV-positive women were encouraged to attend local clinics at 4–6 weeks post partum for early infant diagnosis, initiation of cotrimoxazole prophylaxis and, for HIV-infected children, ART initiation. Infants born to HIV-positive mothers were eligible for enrolment into a substudy in which biological specimens were collected longitudinally. For substudy infants, blood was tested for HIV (by PCR or rapid test, depending on age and sample) at 1, 3, 6, 12 and 18 months; infants not enrolled into the substudy were tested at 18 months. HEU children were defined as being born to HIV-positive mothers and testing HIV-negative at 18 months of age. HIV-exposed children, who were not tested at 18 months because of maternal refusal, missed visits or failure to obtain a specimen or children who had inconclusive/discordant HIV results after retesting, were classified as HIV unknown. All HIV-positive children were referred to clinics for ART initiation. Research nurses made home visits at baseline (~2 weeks after consent), 32 weeks’ gestation and at 1, 3, 6, 12 and 18 months postpartum to assess maternal and household characteristics and trial outcomes. Intervention uptake was assessed by participant behaviours at the 12-month postnatal visit. Infants who completed the trial and turned 2 years of age (allowable range 102–112 weeks) between 1 March 2016 and 30 April 2017 were eligible to join the ECD substudy. Children were enrolled either during the 18-month trial endpoint visit, or following the 18 month SHINE visit but before the child turned 2 years of age. A team of 11 research nurses completed 3 weeks of residential training in ECD assessment by the team psychologist (JC) and a neurodevelopmental paediatrician (MG). Several domains of ECD were assessed. The ECD substudy design and outcomes were prespecified in the study protocol and statistical analysis plan (https://osf.io/w93hy). The primary outcomes were MDAT total (out of 138), gross motor (out of 36), fine motor (out of 36), social (out of 30) and language (out of 36) scores; MacArthur Bates CDI vocabulary checklist (number of words known out of 99); A-not-B score (out of 10); and the proportion of children with self-control. The secondary outcomes were the proportion of children using the progressive tense, using plurals or combining two words (MacArthur Bates CDI grammar checklist). Children with severe motor, visual, hearing or learning impairments as determined by the Washington Group questionnaire (child version)17 were excluded from analyses and referred to local clinics. Every 6 months, nurses underwent refresher training and standardisation. Each nurse was observed while conducting an ECD assessment while a gold-standard assessor double-scored the assessment; percentage agreement had to be >85% for certification, with retraining and retesting required for those who did not meet this threshold. In addition, all 11 nurses concurrently scored the same child: average interclass correlations across standardisations were: MDAT 0.88 (95% CI 0.82 to 0.94); MacArthur Bates 0.94 (95% CI 0.90 to 0.96); A-not-B 0.85 (95% CI 0.80 to 0.90) and self-control task 0.80 (95% CI 0.76 to 0.85). Supportive supervision was undertaken during monthly field visits and nurses were provided with corrective or reinforcing feedback. A 5% subsample of assessments were video recorded, reviewed and double scored by a psychologist (JC) and a neurodevelopmental paediatrician with Shona language proficiency (GK). Percentage agreement for these video-taped assessments was 93% for MDAT fine motor, 90% for MDAT language, 97% for A-not-B and 91% for the self-control task. All analyses were intention to treat at the child level. The absolute difference in mean score between treatment groups was estimated for tests with continuous outcomes. For tests with dichotomous outcomes, the relative risk (RR) of passing was compared between treatment groups. Primary analyses used generalised estimating equations to account for within-cluster correlation, containing two dummy variables for the two interventions, representing the main effect of the IYCF intervention (the two IYCF-containing groups compared with the two groups without IYCF) and the WASH intervention (the two WASH-containing groups compared with the two groups without WASH), unadjusted for other covariates, with an exchangeable working correlation structure. For each outcome, we estimated the statistical interaction between the IYCF and WASH interventions. When the interaction was significant (p<0.05 according to the Wald test), results are based on a regression model with three dummy variables to represent IYCF, WASH and IYCF +WASH compared with SOC, instead of the model with two terms. Adjusted analyses controlled for prespecified baseline covariates (mother’s mid-upper arm circumference, mother’s education, mother’s employment, maternal health perception, maternal capabilities, improved latrine, low birth weight, prematurity, sex, calendar month, fieldworker, decimal age), which were initially assessed in bivariate analyses to identify those with an important association with the outcome (for dichotomous outcomes: p2.0 or <0.5; for continuous outcomes: p0.25 SD). Selected covariates were entered in a multivariable regression model; a forward stepwise selection procedure was implemented with p<0.2 to enter. A log-binomial specification was used to estimate RRs. Methods for comparing study arms while handling within-cluster correlation included multinomial and ordinal regression models with robust variance estimation, and Somers’ D for medians, were all implemented in Stata V.14. In a sensitivity analysis, HIV-positive and HIV-unknown children were excluded. A subgroup analysis by child gender was planned if there was a significant interaction between gender and study arms (as defined above). The sample size of the ECD substudy was based on detecting clinically relevant differences among HIV-unexposed children10; there was no specific sample size calculation for HIV-exposed children. We did not directly include patient and public involvement in this trial, but all community activities were discussed with traditional and elected leaders in both study districts, who provided advice through the District Health Executive, Social Services Committee and Rural District Council. A film of the SHINE trial is being made with community participation to capture the experience of being involved in a community-wide trial. The film will be screened in the two rural districts where SHINE was conducted. Study funders approved the trial design, but were not involved in data collection, analysis or interpretation, nor decisions related to publication. The corresponding author had full access to all study data and ultimate responsibility for the decision to submit for publication. An independent data safety and monitoring board reviewed interim adverse event data.
N/A